Wu et al. demonstrated that B7-H6 was presented in B-cell NHL, and the downregulation of B7-H6 inhibited cancer progression and reinforced chemosensitivity against vincristine and dexamethasone [16]. This evidence concerns the gene NCR3LG1 and B-cell non-Hodgkin lymphoma.